Head to head
Humana vs UnitedHealth
Side-by-side on the measures that matter, with a plain-English read. Full detail: HUM · UNH
HUM
Humana
396.51-1.92%
1-year price shape — +36% over the period
Quant Rating B · 75/100
vs
UNH
UnitedHealth
375.98-0.09%
1-year price shape — +5% over the period
Quant Rating C · 47/100
1-year performance, rebased to 100
UnitedHealth edges it on the scoreable measures. UnitedHealth trades cheapest on trailing earnings; UnitedHealth pays the highest dividend yield; UnitedHealth earns the most per share.
| HUM | UNH | |
|---|---|---|
| Snapshot | ||
| Sector | Healthcare Plans | Healthcare Plans |
| Last price | 396.51 | 375.98 |
| Change today | -1.92% | -0.09% |
| 1-year return | +35.8% | +5.5% |
| Market cap | $47.61B | $337.48B |
| 52-week range | 161.90 – 428.88 | 252.95 – 458.79 |
| Valuation | ||
| P/E (TTM) | 37.48 | 24.16 |
| P/E percentile, own 5-yr range | 95th | 46th |
| P/B | 2.48 | 3.43 |
| Dividend yield | 0.89% | 2.38% |
| Profitability & growth | ||
| EPS (TTM) | 9.84 | 13.23 |
| Net profit (TTM) | $1.18B | $11.88B |
| Revenue (TTM) | $145.68B | $450.13B |
| Revenue growth (YoY) | +26.2% | +0.4% |
| Gross margin | -- | 19.5% |
| Operating margin | -- | 4.8% |
| Net margin | 0.9% | 3.1% |
| Free cash flow (TTM) | $1.95B | $23.62B |
| Ownership & sentiment | ||
| Institutional ownership | 101.2% | 89.3% |
| Insider activity (12mo) | 37 buy / 8 sell | 46 buy / 4 sell |
| Short interest (% of float) | 2.4% | 1.5% |
| Analyst consensus | 55% buy / 41% hold / 5% sell (22) | 81% buy / 19% hold (21) |
| Analyst price target | $428 (+8%) | $487 (+30%) |
| StockVane view | ||
| StockVane Quant Rating | B (75) | C (47) |
| Company | ||
| Employees | 67,060 | 390,000 |
| Founded | 1961 | -- |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.